IMPACT OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION ON DIABETES RELATED COMPLICATIONS AND ASSOCIATED COSTS IN TYPE 2 DIABETES PATIENTS IN FINLAND

被引：0
|
作者：
Roze, S. [1 ]
Delbaere, A. [2 ]
de Portu, S. [2 ]
Bjornstrom, K. [3 ]
Honkasalo, M. [4 ]
机构：
[1] Heva Heor Sarl, Hlth Econ, Lyon, France
[2] Medtron Int Sarl, Diabet, Tolochenaz, Switzerland
[3] Medtronic, Medtron Finland, Vantaa, Finland
[4] Nurmijarvi Hlth Ctr, Diabetol Ward, Nurmijarvi, Finland
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2018年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
057
引用
收藏
页码：A27 / A28
页数：2
相关论文
共 50 条
  • [1] IMPACT OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION ON DIABETES RELATED COMPLICATIONS AND ASSOCIATED COSTS IN TYPE 2 DIABETES PATIENTS IN SWEDEN
    Roze, S.
    Duteil, E.
    Delbaere, A.
    De Portu, S.
    Brandt, A. S.
    Hellman, J.
    Frid, A.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A19 - A19
  • [2] Continuous subcutaneous insulin infusion for type 2 diabetes
    Choudhary, Pratik
    LANCET, 2014, 384 (9950): : 1240 - 1242
  • [3] Continuous subcutaneous insulin infusion (CSII) in patients with Type 2 diabetes
    Lenhard, MJ
    Maser, RE
    DIABETES, 2001, 50 : A440 - A441
  • [4] Impact of Medicare Continuous Subcutaneous Insulin Infusion Policies in Patients With Type 1 Diabetes
    Argento, Nicholas B.
    Liu, Jingwen
    Hughes, Allyson S.
    McAuliffe-Fogarty, Alicia H.
    JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2020, 14 (02): : 257 - 261
  • [5] REDUCTION OF COMPLICATIONS AND ASSOCIATED COSTS FOR TYPE 2 DIABETIC PATIENTS USING CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IN THE UK
    Roze, S.
    Duteil, E.
    Hallas, N.
    de Portu, S.
    VALUE IN HEALTH, 2015, 18 (07) : A360 - A360
  • [6] Insulin Pump for Type 2 Diabetes Use and misuse of continuous subcutaneous insulin infusion in type 2 diabetes
    Reznik, Yves
    Cohen, Ohad
    DIABETES CARE, 2013, 36 : S219 - S225
  • [7] Continuous subcutaneous insulin infusion in older patients with type 1 diabetes
    Siegel-Czarkowski, L
    Herold, KC
    Goland, RS
    DIABETES CARE, 2004, 27 (12) : 3022 - 3023
  • [8] Continuous subcutaneous insulin infusion in diabetes: when Type 2 diabetes is not a NICE label
    Paxton, C. A.
    Rainford, A.
    Ooi, C. G.
    DIABETIC MEDICINE, 2008, 25
  • [9] Use of continuous subcutaneous insulin infusion pump in patients with type 2 diabetes mellitus
    Nielsen, S
    Kain, D
    Szudzik, E
    Dhindsa, S
    Garg, R
    Dandona, P
    DIABETES EDUCATOR, 2005, 31 (06): : 843 - 848
  • [10] Impact of continuous subcutaneous insulin infusion (CSII) therapy on retinopathy in patients with Type 1 diabetes
    Khan, I.
    Hopley, D.
    Glover, L.
    Bett, S.
    Young, S.
    Ratcliffe, J.
    Martin, P.
    Krishnan, S.
    Bharaj, H.
    Banerjee, M.
    DIABETIC MEDICINE, 2019, 36 : 73 - 73
12345